Contribution of proteasome-catalyzed peptide


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
03 12 2019
Historique:
pubmed: 22 11 2019
medline: 14 4 2020
entrez: 22 11 2019
Statut: ppublish

Résumé

Peptides generated by proteasome-catalyzed splicing of noncontiguous amino acid sequences have been shown to constitute a source of nontemplated human leukocyte antigen class I (HLA-I) epitopes, but their role in pathogen-specific immunity remains unknown. CD8

Identifiants

pubmed: 31748275
pii: 1911622116
doi: 10.1073/pnas.1911622116
pmc: PMC6900506
doi:

Substances chimiques

AIDS Vaccines 0
Antigens, Viral 0
Epitopes, T-Lymphocyte 0
Histocompatibility Antigens Class I 0
Peptides 0
RNA, Viral 0
Viral Proteins 0
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24748-24759

Subventions

Organisme : Medical Research Council
ID : MC_UU_12009
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 097813/Z/11/B#
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M00919X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K012037
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : P01 AI131251
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118549
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI144371
Pays : United States
Organisme : Medical Research Council
ID : G0902418
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K012037/1
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : UM1 AI100645
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12025
Pays : United Kingdom

Informations de copyright

Copyright © 2019 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

J Immunol. 1994 Jan 15;152(2):620-31
pubmed: 7506728
J Med Virol. 1989 Jun;28(2):81-9
pubmed: 2738583
Sci Rep. 2015 Feb 09;5:8333
pubmed: 25660536
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):E323-31
pubmed: 21670269
Science. 2016 Oct 21;354(6310):354-358
pubmed: 27846572
Science. 2016 Feb 12;351(6274):711-4
pubmed: 26912858
BMC Genomics. 2008 Oct 16;9:488
pubmed: 18925949
Science. 2013 May 24;340(6135):1237874
pubmed: 23704576
J Immunol. 2009 Jun 1;182(11):7131-45
pubmed: 19454710
Nature. 2013 Oct 3;502(7469):100-4
pubmed: 24025770
J Infect Dis. 2017 Dec 12;216(11):1415-1424
pubmed: 28968792
Front Immunol. 2015 Jul 02;6:335
pubmed: 26191062
Science. 2004 Apr 23;304(5670):587-90
pubmed: 15001714
J Virol. 2008 Apr;82(8):3952-70
pubmed: 18256145
Viruses. 2015 Jan 19;7(1):199-218
pubmed: 25606970
Proc Natl Acad Sci U S A. 1988 Jan;85(1):227-31
pubmed: 3257565
Nat Microbiol. 2017 Aug 24;2:17117
pubmed: 28836574
Nat Rev Immunol. 2010 Jan;10(1):11-23
pubmed: 20010788
PLoS One. 2008;3(10):e3460
pubmed: 18941630
Bioinformatics. 2016 Feb 15;32(4):511-7
pubmed: 26515819
Nucleic Acids Res. 2019 Apr 8;47(6):3086-3100
pubmed: 30624716
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Science. 2006 Sep 8;313(5792):1444-7
pubmed: 16960008
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599
pubmed: 28069935
Mol Cell Proteomics. 2018 Dec;17(12):2347-2357
pubmed: 30171158
J Exp Med. 2009 Jun 8;206(6):1253-72
pubmed: 19487423
Front Immunol. 2018 Jul 16;9:1643
pubmed: 30061897
Sci Rep. 2016 Apr 06;6:24032
pubmed: 27049119
J Proteome Res. 2019 Jan 4;18(1):349-358
pubmed: 30346791
Cell Rep. 2016 Nov 22;17(9):2210-2220
pubmed: 27880898
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
J Immunol. 2010 Mar 15;184(6):3016-24
pubmed: 20154207
Cell Rep. 2017 Aug 1;20(5):1242-1253
pubmed: 28768206
J Immunol. 2014 Feb 15;192(4):1962-71
pubmed: 24453253
Science. 2003 Sep 5;301(5638):1367-71
pubmed: 12958358
Front Immunol. 2018 Apr 27;9:912
pubmed: 29780384
Cell Host Microbe. 2016 Mar 9;19(3):292-303
pubmed: 26922989
Sci Immunol. 2018 Oct 12;3(28):
pubmed: 30315122
J Clin Invest. 2016 Feb;126(2):455-63
pubmed: 26731469
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4507-12
pubmed: 24616531
Front Immunol. 2015 Oct 02;6:506
pubmed: 26483795
Eur J Immunol. 2016 May;46(5):1109-18
pubmed: 26909514
Nature. 2004 Jan 15;427(6971):252-6
pubmed: 14724640
Rapid Commun Mass Spectrom. 2003;17(20):2337-42
pubmed: 14558135
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W281-7
pubmed: 22638583
Mass Spectrom Rev. 2015 Jan-Feb;34(1):43-63
pubmed: 25667941
Nature. 1989 Feb 16;337(6208):651-3
pubmed: 2465495

Auteurs

Wayne Paes (W)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom; wayne.paes@ndm.ox.ac.uk nicola.ternette@ndm.ox.ac.uk persephone.borrow@ndm.ox.ac.uk.

German Leonov (G)

York Cross-Disciplinary Centre for Systems Analysis, University of York, York YO10 5DD, United Kingdom.

Thomas Partridge (T)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom.

Takayuki Chikata (T)

Centre for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan.

Hayato Murakoshi (H)

Centre for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan.

Anna Frangou (A)

Big Data Institute, University of Oxford, Oxford OX3 7LF, United Kingdom.

Simon Brackenridge (S)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom.

Annalisa Nicastri (A)

Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.

Andrew G Smith (AG)

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Gerald H Learn (GH)

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Yingying Li (Y)

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Robert Parker (R)

Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.

Shinichi Oka (S)

Centre for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan.
AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo 162-8655, Japan.

Pierre Pellegrino (P)

Centre for Sexual Health and HIV Research, University College London, London WC1E 6JB, United Kingdom.

Ian Williams (I)

Centre for Sexual Health and HIV Research, University College London, London WC1E 6JB, United Kingdom.

Barton F Haynes (BF)

Department of Medicine, Duke University School of Medicine, Durham, NC 27710.
Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710.

Andrew J McMichael (AJ)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom.

George M Shaw (GM)

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Beatrice H Hahn (BH)

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Masafumi Takiguchi (M)

Centre for AIDS Research, Kumamoto University, Kumamoto 860-0811, Japan.

Nicola Ternette (N)

Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom; wayne.paes@ndm.ox.ac.uk nicola.ternette@ndm.ox.ac.uk persephone.borrow@ndm.ox.ac.uk.

Persephone Borrow (P)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, United Kingdom; wayne.paes@ndm.ox.ac.uk nicola.ternette@ndm.ox.ac.uk persephone.borrow@ndm.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH